These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 31577283)
21. Dinuclear Platinum(II) Complexes with Bone-Targeting Groups as Potential Anti-Osteosarcoma Agents. Zhang Z; Wang X; Luo C; Zhu C; Wang K; Zhang C; Guo Z Chem Asian J; 2017 Jul; 12(13):1659-1667. PubMed ID: 28556606 [TBL] [Abstract][Full Text] [Related]
22. Platinum squares with high selectivity and affinity for human telomeric G-quadruplexes. Zheng XH; Chen HY; Tong ML; Ji LN; Mao ZW Chem Commun (Camb); 2012 Aug; 48(61):7607-9. PubMed ID: 22728887 [TBL] [Abstract][Full Text] [Related]
23. Induction of G1 cell cycle arrest and apoptosis by berberine in bladder cancer cells. Yan K; Zhang C; Feng J; Hou L; Yan L; Zhou Z; Liu Z; Liu C; Fan Y; Zheng B; Xu Z Eur J Pharmacol; 2011 Jul; 661(1-3):1-7. PubMed ID: 21545798 [TBL] [Abstract][Full Text] [Related]
24. Synthesis and evaluation of 9-O-substituted berberine derivatives containing aza-aromatic terminal group as highly selective telomeric G-quadruplex stabilizing ligands. Ma Y; Ou TM; Tan JH; Hou JQ; Huang SL; Gu LQ; Huang ZS Bioorg Med Chem Lett; 2009 Jul; 19(13):3414-7. PubMed ID: 19477640 [TBL] [Abstract][Full Text] [Related]
25. Neutral and ionic platinum compounds containing a cyclometallated chiral primary amine: synthesis, antitumor activity, DNA interaction and topoisomerase I-cathepsin B inhibition. Albert J; Bosque R; Crespo M; Granell J; López C; Martín R; González A; Jayaraman A; Quirante J; Calvis C; Badía J; Baldomà L; Font-Bardia M; Cascante M; Messeguer R Dalton Trans; 2015 Aug; 44(30):13602-14. PubMed ID: 26140359 [TBL] [Abstract][Full Text] [Related]
26. Platinum(II) clovers targeting G-quadruplexes and their anticancer activities. Zheng XH; Cao Q; Ding YL; Zhong YF; Mu G; Qin PZ; Ji LN; Mao ZW Dalton Trans; 2015 Jan; 44(1):50-3. PubMed ID: 25373495 [TBL] [Abstract][Full Text] [Related]
27. Synthesis, cytotoxic activity and DNA interaction studies of new dinuclear platinum(ii) complexes with an aromatic 1,5-naphthyridine bridging ligand: DNA binding mode of polynuclear platinum(ii) complexes in relation to the complex structure. Konovalov B; Živković MD; Milovanović JZ; Djordjević DB; Arsenijević AN; Vasić IR; Janjić GV; Franich A; Manojlović D; Skrivanj S; Milovanović MZ; Djuran MI; Rajković S Dalton Trans; 2018 Oct; 47(42):15091-15102. PubMed ID: 30303498 [TBL] [Abstract][Full Text] [Related]
28. Synthesis and anticancer activities of a novel class of mono- and di-metallic Pt(II)(salicylaldiminato)(DMSO or Picolino)Cl complexes. Rahman FU; Ali A; Guo R; Zhang YC; Wang H; Li ZT; Zhang DW Dalton Trans; 2015 Feb; 44(5):2166-75. PubMed ID: 25510629 [TBL] [Abstract][Full Text] [Related]
29. A hybrid platinum drug dichloroacetate-platinum(II) overcomes cisplatin drug resistance through dual organelle targeting. Zhang Y; Guo G; Ma B; Du R; Xiao H; Yang X; Li W; Gao Y; Li Y; Jing X Anticancer Drugs; 2015 Aug; 26(7):698-705. PubMed ID: 25811961 [TBL] [Abstract][Full Text] [Related]
30. Stabilization of human telomeric G-quadruplex and inhibition of telomerase activity by propeller-shaped trinuclear Pt(II) complexes. Xu CX; Shen Y; Hu Q; Zheng YX; Cao Q; Qin PZ; Zhao Y; Ji LN; Mao ZW Chem Asian J; 2014 Sep; 9(9):2519-26. PubMed ID: 24996049 [TBL] [Abstract][Full Text] [Related]
31. Recent Advances in Nucleic Acid Binding Aspects of Berberine Analogs and Implications for Drug Design. Bhowmik D; Kumar GS Mini Rev Med Chem; 2016; 16(2):104-19. PubMed ID: 26349491 [TBL] [Abstract][Full Text] [Related]
32. Pt(IV) prodrugs containing microtubule inhibitors displayed potent antitumor activity and ability to overcome cisplatin resistance. Li L; Huang X; Huang R; Gou S; Wang Z; Wang H Eur J Med Chem; 2018 Aug; 156():666-679. PubMed ID: 30031977 [TBL] [Abstract][Full Text] [Related]
33. Cytotoxicity and induction of apoptosis of human breast cancer cells by novel platinum(II) complexes. Bielawski K; Czarnomysy R; Muszyńska A; Bielawska A; Popławska B Environ Toxicol Pharmacol; 2013 Mar; 35(2):254-64. PubMed ID: 23376176 [TBL] [Abstract][Full Text] [Related]
34. Combretastatin A-4 Analogue: A Dual-Targeting and Tubulin Inhibitor Containing Antitumor Pt(IV) Moiety with a Unique Mode of Action. Huang X; Huang R; Gou S; Wang Z; Liao Z; Wang H Bioconjug Chem; 2016 Sep; 27(9):2132-48. PubMed ID: 27494235 [TBL] [Abstract][Full Text] [Related]
35. Synthesis and anticancer mechanisms of four novel platinum(II) 4'-substituted-2,2':6',2''-terpyridine complexes. Liang CJ; Wu RC; Huang XQ; Qin QP; Liang H; Tan MX Dalton Trans; 2024 Jan; 53(5):2143-2152. PubMed ID: 38189098 [TBL] [Abstract][Full Text] [Related]
36. Remarkable anticancer activity of ferrocenyl-terpyridine platinum(ii) complexes in visible light with low dark toxicity. Mitra K; Basu U; Khan I; Maity B; Kondaiah P; Chakravarty AR Dalton Trans; 2014 Jan; 43(2):751-63. PubMed ID: 24149439 [TBL] [Abstract][Full Text] [Related]
37. Studies on antitumor mechanism of two planar platinum(II) complexes with 8-hydroxyquinoline: synthesis, characterization, cytotoxicity, cell cycle and apoptosis. Qin QP; Chen ZF; Qin JL; He XJ; Li YL; Liu YC; Huang KB; Liang H Eur J Med Chem; 2015 Mar; 92():302-13. PubMed ID: 25575314 [TBL] [Abstract][Full Text] [Related]
39. Impact of Mitochondrion-Targeting Group on the Reactivity and Cytostatic Pathway of Platinum(IV) Complexes. Jin S; Hao Y; Zhu Z; Muhammad N; Zhang Z; Wang K; Guo Y; Guo Z; Wang X Inorg Chem; 2018 Sep; 57(17):11135-11145. PubMed ID: 30117731 [TBL] [Abstract][Full Text] [Related]
40. Morpholine or methylpiperazine and salicylaldimine based heteroleptic square planner platinum (II) complexes: In vitro anticancer study and growth retardation effect on E. coli. Rahman FU; Ali A; Khan IU; Duong HQ; Yu SB; Lin YJ; Wang H; Li ZT; Zhang DW Eur J Med Chem; 2017 May; 131():263-274. PubMed ID: 28334655 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]